Identification by Genomic and Genetic Analysis of Two New Genes Playing a Key Role in Intermediate Glycopeptide Resistance in Staphylococcus aureus

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2009-03, Vol.53 (3), p.903-911
Hauptverfasser:	RENZONI, Adriana, KELLEY, William L, BARRAS, Christine, MONOD, Antoinette, HUGGLER, Elzbieta, FRANCOIS, Patrice, SCHRENZEL, Jacques, STUDER, René, VAUDAUX, Pierre, LEW, Daniel P
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents Anti-Bacterial Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial diseases Biological and medical sciences Comparative Genomic Hybridization Drug Resistance, Microbial Genome, Bacterial Genome, Bacterial - drug effects Glycopeptides Glycopeptides - genetics Glycopeptides - metabolism Human bacterial diseases Humans Infectious diseases Mechanisms of Resistance Medical sciences Microbial Sensitivity Tests Mutation - drug effects Pharmacology. Drug treatments Staphylococcal infections, streptococcal infections, pneumococcal infections Staphylococcus aureus Staphylococcus aureus - drug effects Staphylococcus aureus - genetics Staphylococcus aureus - metabolism Teicoplanin - pharmacology Vancomycin Resistance - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!